Archives of Internal Medicine · 1968 · 67 citations · 12 references
MedicineInternal MedicinePharmacologyClinical PharmacologyHepatologyHepatotoxicologyHepatic ImpairmentHepatic ToxicityHepatotoxicity MechanismsLiver Disease6-Mercaptopurine TherapyPurine Analogues
The appearance of jaundice in patients with acute leukemia treated with mercaptopurine has been described in several reports and attributed to a toxic effect of the therapeutic agent on the liver.<sup>1-6</sup>A number of possible causes of jaundice unrelated to therapy exist in the leukemia patient, and it is difficult to be certain whether all reported instances are indeed produced by the drug. Nevertheless, it is generally accepted that mercaptopurine is potentially hepatotoxic. Recently, we have observed jaundice develop in two nonleukemic patients during therapy with mercaptopurine. Because of increasing current interest in the use of purine analogues for treatment of a variety of diseases, we are reporting our observations in order to direct attention to this important therapeutic complication. <h3>Patient Summaries</h3><h3>Patient 1.</h3> —A 45-year-old man was admitted to Parkland Memorial Hospital on Dec 14, 1966, for evaluation of jaundice. He had been well until July 1964 when
12
A Comparative Study of Two Regimens of Combination Chemotherapy in Acute Leukemia
Emil Frei, James F. Holland, Marvin A. Schneiderman et al. · Blood · 1958 · 182 citations · Full text
Medicine, Oncology, Pharmacology +9
6-Mercaptopurine: effects in mouse sarcoma 180 and in normal animals.
Donald A. Clarke, Frederick S. Philips, Stephen S. Sternberg et al. · PubMed · 1953 · 141 citations
Medicine, Oncology, Pharmacology +13
Hepatotoxicity of Mercaptopurine
Morton Einhorn, I. Davidsohn · JAMA · 1964 · 135 citations
Hepatitis in Association with Prolonged 6-Mercaptopurine Therapy
S.K. Mcilvanie, JOHN D. MacCARTHY · Blood · 1959 · 82 citations · Full text